Author: EndoCyclic Therapeutics

Posted Date:

March 23, 2026

EndoCyclic Therapeutics Announces FDA Clearance of Investigational New Drug (IND) Application for ENDO-205, a First-in-Class Non-Hormonal Precision Peptide Therapeutic for Endometriosis

EndoCyclic Therapeutics

March 23, 2026